Tectonic Therapeutic (TECX) Other financing activities (2017 - 2025)

Tectonic Therapeutic (TECX) reported Other financing activities of -$73000.0 for Q4 2025, up 78.53% quarter-over-quarter from -$340000.0 in Q3 2025.

Tectonic Therapeutic (TECX) Other financing activities (2017 - 2025) Analysis & Trends

Tectonic Therapeutic (TECX) has 4 years of Other financing activities data on file, last reported at -$73000.0 in Q4 2025.

  • Other financing activities for Q4 2025 came in at -$73000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$468000.0 (changed N/A YoY), and the FY2025 annual result was -$468000.0, changed N/A from the prior year.
  • Other financing activities improved to -$73000.0 in Q4 2025 per TECX's latest filing, from -$340000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $554000.0 in Q2 2024 and troughed at -$554000.0 in Q1 2024.
  • A 3-year average of -$45625.0 and a median of -$64000.0 in 2025 frame the typical range for Other financing activities.
  • On a YoY basis, Other financing activities climbed as much as 109.93% in 2025 and fell as far as 109.93% in 2025.
  • A 3-year view of Other financing activities shows it stood at -$101000.0 in 2021, then soared by 648.51% to $554000.0 in 2024, then plunged by 113.18% to -$73000.0 in 2025.
  • Business Quant data shows TECX's Other financing activities at -$73000.0 in Q4 2025, -$340000.0 in Q3 2025, and -$55000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Tectonic Therapeutic 528.16 Mn 291.27 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -73,000.00
Dec 31, 2025 -73,000.00
Sep 30, 2025 -340,000.00
Sep 30, 2025 -340,000.00
Jun 30, 2025 -55,000.00
Jun 30, 2025 -55,000.00
Jun 30, 2024 554,000.00
Jun 30, 2024 554,000.00
Mar 31, 2024 -554,000.00
Mar 31, 2024 -554,000.00
Dec 31, 2021 -101,000.00
Dec 31, 2021 -101,000.00
Jun 30, 2021 255,000.00
Jun 30, 2021 255,000.00
Mar 31, 2021 -51,000.00
Mar 31, 2021 -51,000.00
Sep 30, 2017 12,000.00
Sep 30, 2017 12,000.00